AtriCure Synergy RF Energy Lesions For Non-Paroxysmal Forms Of Atrial Fibrillation Treatment During Concomitant On-Pump Cardiac Surgery Post-Approval Study (or "ABLATE PAS")
To evaluate clinical outcomes in a cohort of patients treated during commercial use of the AtriCure Synergy Ablation System by physicians performing the Maze IV procedure
January 01, 1900
Heart & Vascular - Cardiac Surgery
Glenn R. Barnhart, MD
Subjects, age ≥ 18 years, with Persistent or Longstanding Persistent Atrial Fibrillation, scheduled to undergo elective open cardiac surgical procedure(s) to be performed on cardiopulmonary bypass for one or more of the following: Coronary Artery Bypass Grafting (CABG), Mitral valve repair or replacement, Aortic valve repair or replacement, Tricuspid valve repair or replacement.